Children’s cognitive development: The impact of the pandemic

children’s cognitive development over the lockdown period

The World Economic Forum estimates that globally, during the first year of the COVID-19 pandemic, 1.5 billion pupils were unable to attend school due to lockdowns designed to stop the spread of the disease. Government containment policies were essential to help save lives, but the wider impact of those policies is now the focus of academic research. A new Austrian […]

Read More… from Children’s cognitive development: The impact of the pandemic

Statistics in the era of COVID-19: Measuring lockdowns with doubling time

graph and clock design

The key to understanding SARS-CoV-2 (COVID-19) transmission is understanding the exponential growth of viral transmissions. The problem is that the concept of exponential growth is challenging for many to understand and interpret, including policymakers who need to make quick and informed decisions. Dr Biljana Stangeland, Executive Director/Chief Scientific Officer at Alv B, Norway, has been using doubling time – the […]

Read More… from Statistics in the era of COVID-19: Measuring lockdowns with doubling time

To Test, Or Not To Test – The COVID-19 Question

The research showed that countries with a higher health expenditure identify more positive cases and deaths.

Dr Cristina Isabel Ibarra-Armenta is a lecturer at the Autonomous University of Sinaloa and UNICAF University. Dr Moisés Alejandro Alarcon-Osuna is a lecturer at the University of Guadalajara, and a member of the Mexican System of National Researchers from CONACYT (National Council for Science and Technology). Their research focuses on econometrics, regional analysis, and policy and technology change. In a […]

Read More… from To Test, Or Not To Test – The COVID-19 Question

Dihydromyricetin shows promise as anxiety disorder treatment

Jing Liang discovered that dihydromyricetin could have potential as a new treatment for anxiety disorders.

Anxiety disorders are one of the most common mental illnesses, and social isolation can be a major source of contributing stress. Medications to treat these disorders, such as benzodiazepines, are available; however, they come with a range of downsides. In a recent study in mice, Prof Jing Liang’s team at the USC School of Pharmacy in the US discovered that […]

Read More… from Dihydromyricetin shows promise as anxiety disorder treatment